New gel shows promise for rosacea Flare-Ups
NCT ID NCT04886739
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a topical gel called CGB-400 in 78 adults with moderate to severe rosacea. Participants applied the gel or a placebo twice daily for 12 weeks. Researchers counted inflammatory lesions and assessed skin clarity to see if the gel reduces symptoms.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- CGB-400 topical gel
- What this could lead to
- If it works, this could offer a new topical option to reduce redness and bumps in people with rosacea.
- What could go wrong
- This is a small, early-phase proof-of-concept study. The gel may not work better than a placebo, and results may not apply to all rosacea patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ROSACEA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cage Bio Investigative Site 1
Fremont, California, 94538, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can light therapy or special skincare tame rosacea redness? a trial puts them to the test
- Can sound waves clear up skin? new trial tests ultrasound for pigment and rosacea
- Can a special cream soothe rosacea redness?
- Rosacea mystery: gut and skin bacteria under the microscope
- New drug offers hope for rosacea sufferers with burning pain
- Ear stimulation device could tame rosacea flushing